Advertisement
Screener

InspireMD, Inc. (NSPR) Overview

InspireMD, Inc. (NSPR) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.17; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.16; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.17; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.26; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.62$0.80$1.04$1.34$1.74$2.262025-11-062026-11-06$0.62$0.91$1.35$2.00$2.95$4.372021-11-082026-11-06$0.62$6.65$71.66$771.93$8,315.51$89,578.122016-11-072026-11-06$0.62$25.78$1,076.06$44,919.71$1.88M$78.28M2011-04-122026-11-06$0.62$25.78$1,076.06$44,919.71$1.88M$78.28M2011-04-122026-11-06

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$0.67
Previous close
$0.69
Change
-$0.02
Change (%)
-3.01%
Close date
2026-11-06
Previous close date
2026-09-29
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

NSPR
-61.24%
S&P 500
(m)

1 year

NSPR
-71.49%
S&P 500
(m)

3 years

NSPR
-78.90%
S&P 500
(m)

5 years

NSPR
-82.92%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.17

-0.34-0.160.030.210.4031 Mar 2025: estimate (m); actual 0.2231 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.2630 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.1730 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.1631 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.1730 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.17(m)(m)
1 Jan 202631 Mar 2026(m)-0.16(m)(m)
1 Jul 202530 Sept 2025(m)-0.17(m)(m)
1 Apr 202530 Jun 2025(m)-0.26(m)(m)
1 Jan 202531 Mar 2025(m)0.22(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.76

-2.43-1.97-1.51-1.04-0.5831 Dec 2022: estimate (m); actual -2.3531 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.8231 Dec 2023(m)31 Dec 2024: estimate (m); actual -0.7631 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.7631 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.76(m)(m)
1 Jan 202431 Dec 2024(m)-0.76(m)(m)
1 Jan 202331 Dec 2023(m)-0.82(m)(m)
1 Jan 202231 Dec 2022(m)-2.35(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 1.77M ■ Earnings -14.32M — Profit margin -808.81%

-16.45M-809.8%-9.13M-664.1%-1.80M-518.3%5.52M-372.5%30 Sept 2025: revenue 2.52M; earnings -12.71M; profit margin -503.69%30 Sept 202531 Dec 2025: revenue 3.15M*; earnings -11.76M*; profit margin -373.55%*; Revenue: Annual amount − nine-month amount; Earnings: Annual amount − nine-month amount; period 2025-10-01 to 2025-12-31; USD.31 Dec 202531 Mar 2026: revenue 3.40M; earnings -13.69M; profit margin -402.85%31 Mar 202630 Jun 2026: revenue 1.77M; earnings -14.32M; profit margin -808.81%30 Jun 2026

31 Dec 2025 ■ Revenue 8.98M ■ Earnings -48.79M — Profit margin -543.36%

-55.72M-544.4%-31.84M-469.6%-7.97M-394.8%15.91M-320.0%31 Dec 2022: revenue 5.17M; earnings -18.49M; profit margin -357.59%31 Dec 202231 Dec 2023: revenue 6.21M; earnings -19.92M; profit margin -320.97%31 Dec 202331 Dec 2024: revenue 7.01M; earnings -32.01M; profit margin -456.63%31 Dec 202431 Dec 2025: revenue 8.98M; earnings -48.79M; profit margin -543.36%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$0.67(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$0.67High(m)Average(m)Low(m)2025-11-062026-11-06

Recent news

View more →

(m)

YouTube videos mentioning NSPR

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-52.48M
Profit margin
-484.13%
Return on assets · 12 month
-134.60%
Index membership
(m)
Employees
127.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
51.07K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-9.21%*
Total return · month
-18.82%*
Total return · quarter
1.47%*
Total return · half year
-56.60%*
Total return · year to date
-61.24%*
Total return · 1 year
-71.49%*
Total return · 3 years
-78.90%*
Total return · 5 years
-82.92%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$10.84M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

InspireMD, Inc. Overview

View more →

(m)

(m)

SEC CIK
1433607
Industry (SIC)
3841 Surgical & Medical Instruments & Apparatus
Country of operation
United States
Business address
6303 WATERFORD DISTRICT DRIVE, SUITE 215, MIAMI, Florida, 33126, United States
Fiscal year end
1231
Phone
(888) 776-6804

Similar stocks

Stock NameCountryMarket CapPE Ratio
PAVmed Inc. (PAVM)United States$0.031B-3.00
Glucotrack, Inc. (GCTK)United States$0.027B
ACCURAY INC (ARAY)United States$0.027B-0.63
SANUWAVE Health, Inc. (SNWV)United States$0.041B5.47
HeartBeam, Inc. (BEAT)United States$0.022B-2.08
RETRACTABLE TECHNOLOGIES INC (RVP)United States$0.021B-6.44
FEMASYS INC (FEMY)United States$0.020B-1.07
NEPHROS INC (NEPH)United States$0.046B23.02
Modular Medical, Inc. (MODD)United States$0.018B-0.88
Sensus Healthcare, Inc. (SRTS)United States$0.048B-3.24